B. Metzler seel. Sohn & Co. AG Buys 6,191 Shares of Cigna Group $CI

Key Points

• B. Metzler seel. Sohn & Co. AG increased its stake in Cigna by 28.2% in Q4, buying 6,191 shares to hold 28,150 shares valued at about $7.75 million.
• Cigna beat quarterly expectations with EPS of $8.08 (vs. $7.88 est.) and revenue of $72.5B (vs. $69.53B), set FY2026 guidance around ~30.25 EPS, and carries a consensus analyst rating of "Moderate Buy" with an average target near $332.47.
• The company announced a quarterly dividend of $1.56 ($6.24 annualized, ~2.2% yield; ex-dividend June 4), while insiders have recently sold shares and institutional investors own roughly 87% of the stock.

B. Metzler seel. Sohn & Co. AG boosted its stake in Cigna Group (NYSE:CI - Free Report) by 28.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,150 shares of the health services provider's stock after purchasing an additional 6,191 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Cigna Group were worth $7,748,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Harbor Capital Advisors Inc. boosted its stake in Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider's stock worth $26,000 after purchasing an additional 49 shares during the period. Beacon Financial Strategies CORP bought a new position in Cigna Group in the 4th quarter worth about $28,000. Collier Financial bought a new stake in shares of Cigna Group during the 3rd quarter valued at about $34,000. Lodestone Wealth Management LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at about $32,000. Finally, Founders Capital Management boosted its position in shares of Cigna Group by 53.0% during the 3rd quarter. Founders Capital Management now owns 153 shares of the health services provider's stock valued at $44,000 after acquiring an additional 53 shares during the last quarter. Institutional investors own 86.99% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on CI shares. Truist Financial lifted their price target on Cigna Group from $320.00 to $350.00 and gave the company a "buy" rating in a research report on Tuesday, February 17th. Zacks Research upgraded Cigna Group from a "strong sell" rating to a "hold" rating in a research report on Monday, January 5th. UBS Group reiterated a "buy" rating and set a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Cigna Group in a research report on Monday, December 29th. Finally, Barclays dropped their price target on Cigna Group from $305.00 to $303.00 and set an "overweight" rating for the company in a research report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Cigna Group presently has a consensus rating of "Moderate Buy" and an average target price of $332.47.

Cigna Group Stock Performance

Shares of NYSE CI opened at $279.57 on Friday. The stock has a market cap of $73.67 billion, a price-to-earnings ratio of 12.60, a P/E/G ratio of 0.95 and a beta of 0.26. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The stock's 50-day moving average is $274.82 and its 200 day moving average is $277.63.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts' consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to analysts' expectations of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts anticipate that Cigna Group will post 30.32 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group's dividend payout ratio (DPR) is currently 28.13%.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the firm's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the firm's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company's stock.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.